Conclusions on (cost-)effectiveness of pertussis booster vaccination strategies highly dependent on selections made in evidence review.
This letter reacts on a paper recently published in this journal, reviewing the effectiveness and (cost-)effectiveness of pertussis booster vaccination strategies. We argue that a different selection of (cost-)effectiveness data could validly be made than the one presented in the review as being considered most robust. In particular, we explicitly present an alternative set of (cost-)effectiveness data.
Postma
Maarten J
MJ
de Vries
Robin
R
Roord
John
J
D003362:Cost-Benefit Analysis; D006801:Humans; D007117:Immunization, Secondary / Q000191:economics*; D010567:Pertussis Vaccine / Q000191:economics*; D019057:Quality-Adjusted Life Years; D014917:Whooping Cough / Q000517:prevention & control*
D010567:Pertussis Vaccine